Title: Tony W Liang - Innovator in Cancer Research
Introduction
Tony W Liang is a notable inventor based in the United States, recognized for his contributions to cancer research. He has developed innovative solutions aimed at diagnosing and treating various human cancers and diseases.
Latest Patents
Tony W Liang holds a patent titled "Kid3 And Kid3 Antibodies That Bind Thereto." This invention focuses on the identification and characterization of a disease and cancer-associated epitope known as KID3. The patent also includes a family of monoclonal antibodies that bind to KID3, providing methods for diagnosing and treating cancers and diseases that express this epitope. Despite having 0 patents, his work is significant in the field of medical research.
Career Highlights
Tony W Liang is currently employed at Raven Biotechnologies, Inc., where he continues to advance his research in the field of oncology. His work is pivotal in developing new therapeutic approaches for cancer treatment.
Collaborations
Tony collaborates with esteemed colleagues, including Deryk T Loo and Xiaolin Xu, who contribute to his research efforts and enhance the impact of his work.
Conclusion
Tony W Liang is a dedicated inventor whose research in cancer-associated epitopes and monoclonal antibodies holds promise for future advancements in cancer diagnosis and treatment. His contributions to the field are invaluable and continue to inspire innovation in medical research.